Table 1.
Clinicopathological features of patients with resected pancreatic cancer, n (%)
| Features | n = 582 |
| Age [yr, median (range)] | 61 (29-82) |
| Gender (male/female) | 319(54.8)/263(45.2) |
| Tumour location (head/body, tail) | 243(41.8)/339 (58.2) |
| Preoperative CA19-9 (> 37 U/mL/≤ 37 U/mL) | 440 (75.6)/142 (24.4) |
| HALP (> 44.56/≤ 44.56) | 351 (60.3)/231 (39.7) |
| NLR (> 2.20/≤ 2.20) | 287 (49.3)/295 (50.7) |
| PLR (> 112.94/≤ 112.94) | 331 (56.9)/251 (43.1) |
| PNI (> 53.10/≤ 53.10) | 249 (42.8)/333 (57.2) |
| Tumour size (cm, median (range)) | 4.0 (0.3-11.5) |
| Lymph node metastasis (more than 3/1-3/0 positive lymph nodes) | 75 (12.9)/210 (36.1)/297 (51.0) |
| Total lymph nodes resected [median (range)] | 12 (1-69) |
| TNM stage (IA/IB/IIA/IIB/III) | 39 (6.7)/164 (28.2)/94 (16.2)/210 (36.0)/75 (12.9) |
| Differentiation (well, moderate/poor) | 361 (62.0)/221 (38.0) |
| Neural invasion (yes/no) | 476 (81.8)/106 (18.2) |
| Microvascular invasion (yes/no) | 126 (21.6)/456 (78.4) |
HALP: Hemoglobin, albumin, lymphocyte, and platelet; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; PNI: Prognostic nutritional index.